The innate immune system in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the leading cause for dementia in the world. It is characterized by two biochemically distinct types of protein aggregates: amyloid β (A β ) peptide in the forms of parenchymal amyloid plaques and congophilic amyloid angiopathy (CAA) and aggregated tau protein in the form of intraneuronal neurofibrillary tangles (NFT). Several risk factors have been discovered that are associated with AD. The most well-known genetic risk factor for late-onset AD is apolipoprotein E4 (ApoE4) (Potter and Wisniewski (2012), and Verghese et al. (2011)). Recently, it has been reported by two groups independently that a rare functional variant (R47H) of TREM2 is associated with the late-onset risk of AD. TREM2 is expressed on myeloid cells including microglia, macrophages, and dendritic cells, as well as osteoclasts. Microglia are a major part of the innate immune system in the CNS and are also involved in stimulating adaptive immunity. Microglia express several Toll-like receptors (TLRs) and are the resident macrophages of the central nervous system (CNS). In this review, we will focus on the recent advances regarding the role of TREM2, as well as the effects of TLRs 4 and 9 on AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TREM2 suppresses inflammation by inhibiting the production and secretion of cytokines that are initiated by TLR2 and TLR4 signaling [29]”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · cited 1×
“TLR11, 12, and 1 that are not present in the human genome [50].”
BackgroundDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · cited 1×
“It recognizes microbial motifs of LPS (lipopolysaccharides) [62, 63].”
BackgroundA Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 4×
“TLR9 was originally identified as a receptor that could differentially recognize bacterial DNA versus mammalian DNA, based on the high frequency of hypomethylated CpG motifs in nonmammalian DNA [71, 72].”
BackgroundInfluentialTakeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590 · cited 2×
“Toll was first identified as a receptor expressed by insects and was found to be essential for establishing dorsal-ventral orientation during embryonic development in Drosophila melanogaster [42] and for being important for defense against microbial infection [43, 44].”
BackgroundLemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.-M., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,043
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“Subsequently, this association was replicated in cohorts from the USA, Germany, The Netherlands, and Norway [9].”
Result
Research works printed but not linked: 6
- 10.1001/jamaneurol.2013.579 · DOI · Paper page
- 10.1086/342259 · DOI · Paper page
- 10.1007/978-3-642-00549-7-8 · doi:10.1007/978-3-642-00549-7-8
- 2006, Current Topics in Microbiology and Immunology, 311, 1
- 1992, Acta Neuropathologica, 84, 225
- 1994, Neuropathology and Applied Neurobiology, 20, 192
Cited by
Clearance systems in the brain—implications for Alzheimer disease
Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., Axel, L., Rusinek, H., Nicholson, C., Zlokovic, B. V., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.119 · Cited by 1,678
Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
Microglial dysfunction in brain aging and Alzheimer's disease
Mosher, K. I., & Wyss-Coray, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.008 · Cited by 618
“Additionally, TREM2 suppresses inflammation by inhibiting the production and secretion of cytokines that are initiated by TLR2 and TLR4 signaling [29] (Fig.”
BackgroundInflammatory Response in the CNS: Friend or Foe?
Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573
Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
Sadigh-Eteghad, S., Sabermarouf, B., Majdi, A., Talebi, M., Farhoudi, M., & Mahmoudi, J. (2015) · Medical Principles and Practice · doi:10.1159/000369101 · Cited by 537
Adrenergic regulation of innate immunity: a review
Scanzano, A., & Cosentino, M. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00171 · Cited by 323
“…2013), systemic sclerosis (O’Reilly, 2014), multiple sclerosis, and other demyelinating disease (Mayo et al., 2012), neurodegenerative disease (Boutajangout and Wisniewski, 2013), and only as example, obesity (Lumeng, 2013) and diabetes (Lee, 2014) or that innate immunity play a role in…”
BackgroundImmunotherapeutic Approaches for Alzheimer’s Disease
Wisniewski, T., & Goñi, F. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.064 · Cited by 284
Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Rajesh, Y., & Kanneganti, T.-D. (2022) · Cells · doi:10.3390/cells11121885 · Cited by 262
Paudel, Y. N., Angelopoulou, E., Piperi, C., Othman, I., Aamir, K., & Shaikh, M. F. (2020) · Cells · doi:10.3390/cells9020383 · Cited by 257
Microbial-generated amyloids and Alzheimer's disease (AD)
Hill, J. M., & Lukiw, W. J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00009 · Cited by 173
“…the elevated oxidative stress, aberrant immune-activation and chronic inflammation characteristic of AD brain (Armstrong, 2006; Cui et al., 2007; Van Broeck et al., 2007; Boutajangout and Wisniewski, 2013; Furukawa and Nukina, 2013; Ferrera et al., 2014; Serpente et al., 2014; Takeda et al., 2014).”
BackgroundPathogenic microbes, the microbiome, and Alzheimer’s disease (AD)
(2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00127 · Cited by 169
Bhattacharjee, S., Zhao, Y., Dua, P., Rogaev, E. I., & Lukiw, W. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150211 · Cited by 147
“Interestingly all these 5 miRNAs have been extensively studied and previously categorized as being inducible and regulated by the pro-inflammatory transcription factor NF-kB [14,16,19,30].”
BackgroundFast-spiking parvalbumin-positive interneurons in brain physiology and Alzheimer’s disease
Hijazi, S., Smit, A. B., & van Kesteren, R. E. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02168-y · Cited by 162
“Activated microglia are present in close proximity of amyloid plaques [184 – 186].”
BackgroundMicrobial Sources of Amyloid and Relevance to Amyloidogenesis and AlzheimerÂ’s Disease (AD)
Dua P, Z. Y. (2015) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000177 · Cited by 137
“The recognition of Aβ42 peptides and their misfolded aggregates by microglial surveillance systems, and the inability of microglial cells to deal with these toxic, pro-inflammatory inclusions, especially in their multimeric and aggregated form are thought to form the molecular basis for the aberrant immune activation,…”
BackgroundDopaminergic Regulation of Innate Immunity: a Review
Pinoli, M., Marino, F., & Cosentino, M. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9749-2 · Cited by 136
Maffioletti, E., Tardito, D., Gennarelli, M., & Bocchio-Chiavetto, L. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00075 · Cited by 121
“Interestingly, these AD-specific miRNAs are linked to immunity-related pathways, in particular innate immunity and T cell activation and differentiation, which have been widely described to be altered in AD (Boutajangout and Wisniewski, 2013; Monsonego et al., 2013).”
BackgroundAlzheimer’s Disease, Inflammation, and the Role of Antioxidants
Sinyor, B., Mineo, J., & Ochner, C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200171 · Cited by 120
“TREM2 is an innate immune receptor expressed on the cell surface of microglia that causes macrophages to activate phagocytosis causing the release of reactive oxygen species [11].”
BackgroundThe Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Disease
Hill, J. M., Bhattacharjee, S., Pogue, A. I., & Lukiw, W. J. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00043 · Cited by 98
“Progressive neurological disorders such as AD have been increasingly linked to altered autoimmune and faulty innateimmune responses (12, 40, 41).”
BackgroundAnti-Viral Properties of Amyloid-β Peptides
Bourgade, K., Dupuis, G., Frost, E. H., & Fülöp, T. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160517 · Cited by 96
“of cells including microglia [74, 75], phospholipase”
Inflammation in Alzheimer’s Disease and Molecular Genetics: Recent Update
Zhang, Z.-G., Li, Y., Ng, C. T., & Song, Y.-Q. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0351-0 · Cited by 86
“could reduce inflammation-induced innocent bystander neuronal damage (Boutajangout and Wisniewski 2013).”
BackgroundCould Alzheimer’s Disease Originate in the Periphery and If So How So?
Morris, G., Berk, M., Maes, M., & Puri, B. K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1092-y · Cited by 83
“gene are strongly associated with an increased risk of late onset AD (LOAD) development [148, 149].”
BackgroundKiyota, T., Machhi, J., Lu, Y., Dyavarshetty, B., Nemati, M., Yokoyama, I., Mosley, R. L., & Gendelman, H. E. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.009 · Cited by 80
Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells
Baaklini, C. S., Rawji, K. S., Duncan, G. J., Ho, M. F. S., & Plemel, J. R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00225 · Cited by 79
“Many of these innate immune cells can inflict tissue damage (Mayo et al., 2012; Boutajangout and Wisniewski, 2013; Courties et al., 2014), but little is known about their role in remyelination.”
BackgroundScholtzova, H., Chianchiano, P., Pan, J., Sun, Y., Goñi, F., Mehta, P. D., & Wisniewski, T. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0101-2 · Cited by 77
“There is evidence that neuroinflammation can contribute to cognitive impairment and play a significant role in the disease progression [6,11,66].”
BackgroundResultNeuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 81
“It was reported that overexpression of cytokine IL-1β, which is secreted via astrocytes and microglia adjacent to Aβ plaques, occurs in the brain of AD animal models [84, 85].”
BackgroundAbdelhamid, M., Zhou, C., Ohno, K., Kuhara, T., Taslima, F., Abdullah, M., Jung, C.-G., & Michikawa, M. (2022) · Journal of Alzheimer’s Disease · doi:10.3233/jad-215025 · Cited by 68
Lue, L.-F., Schmitz, C., & Walker, D. G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.050 · Cited by 63
“It is important to investigate the roles of TREM2 in neurodegeneration from the aspect of innate immune function (Boutajangout and Wisniewski, 2013; Golde et al., 2013; Hickman and El, 2013).”
Le Page, A., Bourgade, K., Lamoureux, J., Frost, E., Pawelec, G., Larbi, A., Witkowski, J. M., Dupuis, G., & Fülöp, T. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143054 · Cited by 63
“The complexity of AD as a possible systemic disorder [15–17], the chronic inflammatory status of the disease [21] and the involvement of the innate and adaptive immune systems [18, 19] are focal points that require systematic investigations of the whole immune response involvement in AD.”
BackgroundVida, C., Martinez de Toda, I., Garrido, A., Carro, E., Molina, J. A., & De la Fuente, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01974 · Cited by 62
Developing therapeutic vaccines against Alzheimer’s disease
Wisniewski, T., & Drummond, E. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1121815 · Cited by 59
“[16,17] Additionally, impaired clearance of Aβ from the brain as a consequence of aging and/or inflow of serum”
BackgroundThe Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer’s Disease
Wiatrak, B., Balon, K., Jawień, P., Bednarz, D., Jęśkowiak, I., & Szeląg, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094862 · Cited by 58
“They act through pro-inflammatory cytokines such as TNF-α and IFNγ and are activated through Toll-like receptors (TLR) stimulation [39,79,83].”
BackgroundMethodInfluentialThe Role of TREM2 in Alzheimer’s Disease and Other Neurological Disorders
Yaghmoor, F. (2014) · Journal of Alzheimer's Disease & Parkinsonism · doi:10.4172/2161-0460.1000160 · Cited by 47
“TREM2 is an innate immune receptor expressed on the cell surface of microglia, macrophages, osteoclasts and immature dendritic cells [12-14].”
BackgroundInfluentialAlzheimer’s Disease: From Genetic Variants to the Distinct Pathological Mechanisms
Sun, Q., Xie, N., Tang, B., Li, R., & Shen, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00319 · Cited by 52
“Recently, rare variants of the TREM2 gene have been identified to increase susceptibility to LOAD with an odds ratio similar to that of APOE ε4 (Boutajangout and Wisniewski, 2013). rs75932628 is the most common variant in TREM2 polymorphism.”
ResultWang, J., Lei, X., Cheng, X., Zhang, X., Liu, G., Cheng, J., Xu, Y., Ju, Z., Zhou, W., & Zhang, Y. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0226-6 · Cited by 42
“Some studies report that overexpressing IL-1β leads to an increase in the microglia and astrocytes surrounding Aβ plaques in AD patients and animal models [97, 98].”
Le Page, A., Lamoureux, J., Bourgade, K., Frost, E. H., Pawelec, G., Witkowski, J. M., Larbi, A., Dupuis, G., & Fülöp, T. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170124 · Cited by 41
Helicobacter pylori Urease: Potential Contributions to Alzheimer’s Disease
Uberti, A. F., Callai-Silva, N., Grahl, M. V. C., Piovesan, A. R., Nachtigall, E. G., Furini, C. R. G., & Carlini, C. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063091 · Cited by 43
“Overexpression of pro-inflammatory cytokine IL-1β produced by microglia and astrocytes close to Aβ plaques are recurrent in the brain affected by AD, as well as in animal models of AD [60,61].”
BackgroundTREM2 variants and risk of Alzheimer’s disease: a meta-analysis
Lu, Y., Liu, W., & Wang, X. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2274-2 · Cited by 37
“including macrophages, microglia, and dendritic cells, as well as osteoclasts [16].”
BackgroundBhattacharjee, S., Zhao, Y., & Lukiw, W. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00116 · Cited by 34
“…for relatively rapid self-aggregation into Aβ42 peptide dimers and higher order fibrillar structures via long-range, non-covalent hydrophobic forces that over time promote βpleated sheet conformations (Mager, 1998; Watson et al., 2005; Boutajangout and Wisniewski, 2013; Chang et al., 2013).”
BackgroundEremenko, E., Mittal, K., Berner, O., Kamenetsky, N., Nemirovsky, A., Elyahu, Y., & Monsonego, A. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.019 · Cited by 35
M2b macrophage subset decrement as an indicator of cognitive function in Alzheimer's disease
Hsieh, S., Huang, L., Chang, Y., Hung, C., & Yang, Y. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13000 · Cited by 33
“In addition to APOEε4, the genetic risk factor for late-onset AD, recent studies have concluded that a rare variant (R47H) of triggering receptor expressed on myeloid cells 2 (TREM2) is linked to late-onset AD for its role of innate immunity.(49,50) 0 0 2 4 6 8”
BackgroundLonnemann, N., Hosseini, S., Ohm, M., Geffers, R., Hiller, K., Dinarello, C. A., & Körte, M. (2021) · eLife · doi:10.7554/elife.75889 · Cited by 34
Jones, B. M., Bhattacharjee, S., Dua, P., Hill, J. M., Zhao, Y., & Lukiw, W. J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00094 · Cited by 27
“…(4) the maintenance of homeostatic microglial function that together may diminish amyloidogenesis and the intercellular propagation of pathogenic signaling in the AD affected brain (Boutajangout and Wisniewski, 2013; Guerreiro and Hardy, 2013; Zhao and Lukiw, 2013; Jiang et al., 2014; Figure 1).”
BackgroundHwang, C. J., Lee, H. P., Choi, D., Jeong, H. S., Kim, T. H., Lee, T. H., Kim, Y. M., Moon, D. B., Park, S.-S., Kim, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10504 · Cited by 26
“However, MPTP-induced IL-1β and IL-6 release were inhibited in thiacremonone treated mice striatum and nigra (Figure 5D).”
BackgroundInfluentialFani, L., Ahmad, S., Ikram, M. K., Ghanbari, M., & Ikram, M. A. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12212 · Cited by 30
PC12 and THP-1 Cell Lines as Neuronal and Microglia Model in Neurobiological Research
Balon, K., & Wiatrak, B. (2021) · Applied Sciences · doi:10.3390/app11093729 · Cited by 31
“Both bacterial LPS and amyloid β interact with microglia through Toll-like receptors (TLRs), triggering the inflammatory response, stimulating upregulated production of reactive oxygen species and cytokines and making the phagocytosis of these harmful compounds ineffective, leading to cellular death [40,41].”
BackgroundIntestinal Bacterial Flora and Alzheimer’s Disease
Bostancıklıoğlu, M. (2018) · Neurophysiology · doi:10.1007/s11062-018-9728-0 · Cited by 25
Islam, R., Choudhary, H. H., Zhang, F., Mehta, H., Yoshida, J., Thomas, A. J., & Hanafy, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-96456-y · Cited by 22
Gut Microbiota and Immunotherapy for Alzheimer’s Disease
Dai, C., Liu, F., Iqbal, K., & Gong, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315230 · Cited by 25
“Activation of peripheral innate immune cells may represent early biomarkers of brain pathology, and targeting the innate immune system may present a strategy to modify brain disease progression [95].”
BackgroundRakshit, D., Nayak, S., Kundu, S., Angelopoulou, E., Pyrgelis, E.-S., Piperi, C., & Mishra, A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00789 · Cited by 21
Brain interleukins and Alzheimer’s disease
Abdelhamed, H. G., Hassan, A. A., Sakraan, A., Al-Deeb, R. T., Mousa, D. M., Ezz, H. S. A., Noor, N. A., Khadrawy, Y. A., & Radwan, N. M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01538-5 · Cited by 21
Dhankhar, J., Agrawal, N., & Shrivastava, A. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577302 · Cited by 18
Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias
Shafi, S., Singh, A., Ibrahim, A. M., Alhajri, N., Izneid, T. A., & Pottoo, F. H. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15215 · Cited by 15
“Although TREM2 and APOE are two prominent LOAD genetic risk factors(Fitz et al., 2020), the interplay between these two is much less understood.”
BackgroundInfluentialV., V. (2015) · Biotechnologia Acta · doi:10.15407/biotech8.06.048 · Cited by 17
Nafady, M. H., Sayed, Z. S., Abdelkawy, D. A., Shebl, M. E., Elsayed, R. A., Ashraf, G. M., Perveen, A., Attia, M. S., & Bahbah, E. I. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220419101205 · Cited by 14
Pandey, R. S., Kotredes, K. P., Sasner, M., Howell, G. R., & Carter, G. W. (2023) · BMC Genomics · doi:10.1186/s12864-023-09280-x · Cited by 11
“Trem2 (triggering receptor expressed on myeloid cells 2) is a receptor protein expressed in dendritic cells, macrophages, and microglia either on the plasma membrane, intracellularly, or as a soluble factor [11, 12].”
BackgroundRetinal manifestations and their diagnostic significance in Alzheimer's disease
Abhyankar, S. D., Little, K., Stitt, A. W., & Bhatwadekar, A. D. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251361937 · Cited by 8
“In 20 – 22 LOAD accounts for approximately 95% of all AD cases, 23 with a prevalence of around 30% in individuals over the age of 85.”
Boziki, M. K., Theotokis, P., Kesidou, E., Nella, M., Bakirtzis, C., Karafoulidou, E., Tzitiridou‐Chatzopoulou, M., Doulberis, M., Kazakos, E. I., Deretzi, G., et al. (2024) · Neurology International · doi:10.3390/neurolint16060127 · Cited by 9
Patogenia y tratamientos actuales de la enfermedad de Alzheimer
Cabrera, M. J. A., Pérez, R. M., Ravelo, A. G., Rodriguez, D. H., & Pérez-Davison, G. (2014) · Revista cubana de farmacia · Cited by 24
Sokolik, V. V., & Shulga, S. (2016) · The Ukrainian Biochemical Journal · doi:10.15407/ubj88.03.083 · Cited by 5
“The presen ce of these neuropeptides in biological fluids was attributed to Aβ accumulation in certain parts of brain (hippocampus, frontal cortex, and olfactory bulbs) and to increased permeability of blood-brain barrier due to inflammation [16, 17].”
BackgroundHippocampus-dependent learning in SKAP-HOM deficient mice
Fiedler, A., Grecksch, G., Reinhold, A., Schraven, B. L., & Becker, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.051 · Cited by 4
High-fat Western diet induces retinal and metabolic alterations in APOE3 and APOE4 knock-in mice
Abhyankar, S. D., Luo, Q., Hartman, G. D., Mahajan, N. S., Corson, T. W., Oblak, A. L., Lamb, B. T., & Bhatwadekar, A. D. (2026) · Scientific Reports · doi:10.1038/s41598-025-34776-9 · Cited by 3
Müller Glial Kir4.1 Channel Dysfunction in APOE4 ‐ KI Model of Alzheimer's Disease
Abhyankar, S. D., Xiao, Y., Mahajan, N. S., Luo, Q., Cummins, T., Oblak, A. L., Lamb, B. T., Corson, T. W., & Bhatwadekar, A. D. (2026) · Glia · doi:10.1002/glia.70119 · Cited by 3
Sokolik, V. V. (2015) · Biotechnologia Acta · doi:10.15407/biotech8.03.078 · Cited by 4
“Modification of the inflammatory state of microglia/ macrophage plays prominent role in the course of amyloidosis [81].”
A Novel Method to Identify Differential Pathways in Hippocampus Alzheimer’s Disease
Liu, C.-H., & Liu, L. (2017) · Medical Science Monitor · doi:10.12659/msm.900929 · Cited by 1
“Triggering receptor expressed on myeloid cells 2 protein (TREM2) was expressed on myeloid cells including microglia, which are a major part of the innate immune system in the central nervous system and are also involved in stimulating adaptive immunity to AD [48].”
BackgroundThe Role of Immune Mechanism in the Process of Secondary Brain Injury
黄, 德. (2014) · Advances in Clinical Medicine · doi:10.12677/acm.2014.42004
The Role of Immune Mechanism in the Process of Secondary Brain Injury
Huang, D., & Yang, J. (2014)
Long-term Dietary Fat Intervention Affects Retinal Health in APOE MicePreprint
Abhyankar, S. D., Luo, Q., Hartman, G. D., Mahajan, N. S., Corson, T. W., Oblak, A. L., Lamb, B. T., & Bhatwadekar, A. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.30.667671
Pandey, R. S., Kotredes, K. P., Sasner, M., Howell, G. R., & Carter, G. W. (2023) · Figshare · doi:10.6084/m9.figshare.22621606
Byrne, A. J., Pibuel, M. A., Martínez, J. M. L., & Franco, P. G. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70422
“While many of these populations have been primarily associated with tissue damage and propagation of inflammatory responses (Mayo et al. 2012; Boutajangout and Wisniewski 2013), their specific roles in remyelination remain incompletely understood.”
Metadata
- Authors
- Boutajangout, A., & Wisniewski, T.
- Affiliations
- King Abdulaziz University (SA)
- Department of Neurology, New York University School of Medicine, Alexandria East River Science Park, 450 East 29th Street, Room 802, New York City, NY 10016, USA
- Venue
- International Journal of Cell Biology
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-7
- ISSN
- 1687-8876 (ISSN-L)
- 1687-8884
- PMC
- PMC3809371
- OpenAlex
- W2013165248
- Cited by
- 69
- References
- 93
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 12 · 2014: 14
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Cell Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (NS073502, AG20245)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, innate immunity, TREM2, microglia, TLR4, TLR9, amyloid-beta, tau protein, neurofibrillary tangles, APOE ε4, myeloid cells, neuroinflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.